La Merceria del Diseno
Buying intent
32 tracked signals | Top 15 topics are below | Sales and Marketing are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere La Merceria del Diseno's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
14d ago
2d ago
10d ago
10d ago
17d ago
27d ago
2d ago
17d ago
9d ago
18d ago
2d ago
28d ago
17d ago
2d ago
9d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at La Merceria del Diseno
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileWelcome to Lupin India’s Knowledge platform, a forum specially designed to share curated medical knowledge with you. Lupin India, the fifth largest pharmaceutical company in the Indian Pharmaceutical Market (IPM) by value, contributes nearly quarter of Lupin Limited revenues. In last decade, Lupin India has grown faster than the market and emerged as a significant player in the space of Cardiology
Top accounts researching La Merceria del Diseno
names withheld on the public pageThese are companies whose own people brought up La Merceria del Diseno unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
940 companies · 2,614 people are researching Sales Excellence
La Merceria del Diseno's own team shows 3 signals on this topic. No one outside La Merceria del Diseno has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Career Development57,400 cos · 377,367 people
- Patient Safety2,066 cos · 7,670 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people; Marketing — 1 person
What's been said
public posts by La Merceria del Diseno's teamNo public post naming La Merceria del Diseno has surfaced in the past year, so this is what La Merceria del Diseno's own team is posting about publicly — their topics, in their words.
Pleased to share highlights from a successful chemist training session conducted by Alembic Pharmaceuticals Limited – Modern Trade Vertical for Thulasi Pharmacy , Coimbatore. The session included an introduction to Alembic Pharmaceuticals, our strong healthcare legacy, and a detailed presentation on our key brands for over 100 chemists along with their senior management team. A special thanks to - Abhijeet Thorat & Pritam Jarhad for delivering an excellent brand presentation with detailed insights and effective competition mapping. The program was highly interactive and engaging, reflecting our continuous commitment to empowering channel partners, strengthening relationships, and improving patient healthcare access. #AlembicPharmaceuticals #ThulasiPharmacy #Healthcare #PatientCare #PharmaIndustry #ModernTrade #Coimbatore #Partnership
Apr 2026Happy Birthday, Doctor SANJAY KALRA Your work in balancing hormones and transforming lives is nothing short of remarkable. Wishing you endless success, good health, and happiness in the coming year
Apr 2026Successfully achieved 107% of the Year-to-Date (YTD) target. This result was made possible through dedicated effort and strong team support, reflecting effective collaboration and commitment to our collective goals.
Apr 2026Excellent performance by my team. congratulations to each colleague of my team. This is the consistently 2nd year of success year in LUPIN METABOLIC. FY 2025-26 ACH 103. 74% PCPM 20.73 Lac Attrition - ZERO
Apr 2026